وثيقة
Progress toward elimination of Hepatitis B virus transmission in Oman : impact of Hepatitis B vaccination.
المعرف
DOI: 10.4269/ajtmh.13-0333
المساهمون
Al-Mahrouqi, Salim., مؤلف
Al-Baqlani, Said., مؤلف
Al-Obaidani, Idris., مؤلف
Alexander, James., مؤلف
Patel, Minal K., مؤلف
الناشر
Elsevier.
ميلادي
2013-10
اللغة
الأنجليزية
الملخص الإنجليزي
Approximately 2-7% of the Omani population has chronic hepatitis B virus (HBV) infection. To decrease this burden, universal childhood hepatitis B vaccination was introduced in Oman in 1990. The hepatitis B vaccination strategy and reported coverage were reviewed. To assess the impact of the program on chronic HBV seroprevalence, a nationally representative seroprevalence study was conducted in Oman in 2005. Since 1991, hepatitis B vaccination in Oman has reached almost every eligible child, with reported coverage of 3 97% for the birth dose and 3 94% for three doses. Of 175 children born pre-vaccine introduction, 16 (9.1%) had evidence of HBV exposure, and 4 (2.3%) had evidence of chronic infection. Of 1,890 children born after vaccine introduction, 43 (2.3%) had evidence of HBV exposure, and 10 (0.5%) had evidence of chronic infection. Oman has a strong infant hepatitis B vaccination program, resulting in a dramatic decrease in chronic HBV seroprevalence.
المجموعة
ISSN
0002-9637
URL المصدر
قالب العنصر
مقالات الدوريات